abstract |
The present invention provides a method of treating an autoimmune disease, comprising the step of increasing transepithelial electrical resistance resulting in reduced cell permeability. In addition, methods of treating celiac disease in individuals in need of treatment of celiac disease, including inhibiting epidermal growth factor receptor and inhibiting PAR 2 by administering an antibody directed against single-stranded zonulin. This is provided. |